Port Problems

Totally implantable vascular access devices (TIVADs) are a safe and effective method of providing long-term intravenous therapy for patients with CF and can usually be left in situ for up to 2 years. Special needles are used to access ports and this should only be done by trained staff with strict asepsis.

Overall complication rates of 12-20% have been reported: the most common complications are [18]:

  • Infection manifesting as pain, pyrexia or sepsis (11%)
  • Catheter blockage (7%)
  • Leakage (5%)
  • Vascular thrombosis (4%)
  • Detached and migrating catheter (4%)
  • Malposition (2%)
  • Pneumothorax (1%)
  • Fractured line (<1%)